Patent classifications
C07C59/58
14-HYDROXY-DOCOSAHEXAENOIC ACID COMPOUNDS
The invention describes novel 14-hydroxy docosahexaenoic acid (DHA) analogues, their preparation, isolation, identification, purification and uses thereof.
14-HYDROXY-DOCOSAHEXAENOIC ACID COMPOUNDS
The invention describes novel 14-hydroxy docosahexaenoic acid (DHA) analogues, their preparation, isolation, identification, purification and uses thereof.
14-HYDROXY-DOCOSAHEXAENOIC ACID COMPOUNDS
The invention describes novel 14-hydroxy docosahexaenoic acid (DHA) analogues, their preparation, isolation, identification, purification and uses thereof.
14-HYDROXY-DOCOSAHEXAENOIC ACID COMPOUNDS
The invention describes novel 14-hydroxy docosahexaenoic acid (DHA) analogues, their preparation, isolation, identification, purification and uses thereof.
14-HYDROXY-DOCOSAHEXAENOIC ACID COMPOUNDS
The invention describes novel 14-hydroxy docosahexaenoic acid (DHA) analogues, their preparation, isolation, identification, purification and uses thereof.
POLYESTER POLYOL HAVING ALICYCLIC SKELETON
To provide a polyester polyol which can prevent gelation during the urethane formation reaction in the production of a polyurethane and from which a polyurethane having stable quality can be produced.
A polyester polyol containing 1,3-propanediol having an alicyclic skeleton in a side chain and a dibasic acid component as constituent components, which has an alkali metal content of 20 ppm by mass or less.
POLYESTER POLYOL HAVING ALICYCLIC SKELETON
To provide a polyester polyol which can prevent gelation during the urethane formation reaction in the production of a polyurethane and from which a polyurethane having stable quality can be produced.
A polyester polyol containing 1,3-propanediol having an alicyclic skeleton in a side chain and a dibasic acid component as constituent components, which has an alkali metal content of 20 ppm by mass or less.
Silver ink
Provided is a silver ink including, as a major component, a silver malonate precursor represented by Formula 1 or Formula 2.
Silver ink
Provided is a silver ink including, as a major component, a silver malonate precursor represented by Formula 1 or Formula 2.
PROCESSES AND INTERMEDIATES FOR PREPARING a,w -DICARBOXYLIC ACID-TERMINATED DIALKANE ETHERS
The present disclosure provides a process for the preparation of compounds of formula (III),
##STR00001##
compounds of formula (V),
##STR00002##
and corresponding salts of formula (IV).
##STR00003##
The compounds made by the methods and processes of the invention are particularly useful for administration in humans and animals.